• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    5.44 Up 0.18(3.42%) Apr 29, 4:00PM EDT
    |After Hours : 5.44 0.00 (0.00%) Apr 29, 4:59PM EDT
    Prev Close:5.26
    Open:5.17
    Bid:5.30 x 300
    Ask:6.45 x 500
    1y Target Est:7.93
    Beta:3.10174
    Next Earnings Date:N/A
    Day's Range:5.17 - 5.69
    52wk Range:2.80 - 11.12
    Volume:1,681,408
    Avg Vol (3m):1,777,900
    Market Cap:575.66M
    P/E (ttm):N/A
    EPS (ttm):-1.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 3.42%575.66M
    BAXDown 0.09%24.33B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):40.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.93
    Quarterly EPS Est (Jun-16) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback